Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

The Week In China: Cancer Therapeutics Sues Partner Peregrine

publication date: Apr 2, 2007
Chinese Rights To TNT Therapy In Dispute -- Cancer Therapeutics Laboratories, a California-based pharma that had licensed Tumor Necrosis Therapy technology from Peregrine Pharma (PPHM) for use in China, has filed a cross-complaint suit against Peregrine. The two companies signed a deal in 1995, and CTL won approval of the drug in China in 2004 for use against lung cancer. In January 2007, before CTL began marketing the drug, Peregrine sued CTL, saying CTL had breached the terms of the agreement. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here